Filing Details

Accession Number:
0001401708-21-000016
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-01-29 16:17:56
Reporting Period:
2021-01-27
Accepted Time:
2021-01-29 16:17:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1401708 Nanostring Technologies Inc NSTG Biological Products, (No Disgnostic Substances) (2836) 200094687
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1710720 Chad J. Brown 530 Fairview Avenue N
Seattle WA 98109
Svp, Sales & Marketing No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-01-27 13,710 $0.00 14,150 No 4 A Direct
Common Stock Disposition 2021-01-27 5,481 $63.59 8,669 No 4 F Direct
Common Stock Disposition 2021-01-28 8,229 $63.18 440 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 F Direct
No 4 S Direct
Footnotes
  1. On March 25, 2019, the Reporting Person was granted performance restricted stock units (PSUs). The PSUs vested upon the Reporting Person's satisfaction of certain performance criteria. On January 27, 2021, the Issuer's Board of Directors determined the level at which the corporate performance goals were attained, resulting in the vesting of 13,710 shares of Common Stock underlying the PSUs.
  2. Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of the PSUs and does not represent a sale by the Reporting Person.
  3. The sales reported by Mr. Brown were effected pursuant to a Rule 10b5-1 trading plan adopted on May 15, 2020.